Federated Hermes, Inc. Vera Therapeutics, Inc. Transaction History
Federated Hermes, Inc.
- $43 Billion
- Q4 2024
A detailed history of Federated Hermes, Inc. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,085,986 shares of VERA stock, worth $31.9 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
1,085,986
Previous 414,105
162.25%
Holding current value
$31.9 Million
Previous $18.3 Million
150.98%
% of portfolio
0.11%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$165 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$129 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$98.2 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$87.1 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$86.7 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $795M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...